Cannabis Policy
Nevada Testing Lab May Lose License For Microbial Contaminants and Altered THC Results
The prediction follows a decision of Nevada’s Cannabis Compliance Board on Tuesday, September 27, to deny the lab’s motion to dismiss the case.
Three Medical Cannabis Companies Fined in Australia For Advertising Products as Cancer and Epilepsy Treatments
Three medical cannabis companies have received fines that total almost $1 million (Australian dollars) from Australia’s drugs regulator.
Kentucky Governor Hints That He’ll Legalize Medical Cannabis Via Executive Action
In a press conference on Thursday, September 22, Governor Andy Beshear told journalists that he had received a report from a medical cannabis advisory committee and “there will be some actions forthcoming.”
University of Kentucky Launches its Cannabis Research Center
The new UK Cannabis Center will conduct research on the health effects of cannabis, “including its risks and benefits when used to treat certain medical conditions.”
Canadian Government to Publish Review of Cannabis Legalization
The review was set to start last October, three years after Canada legalized recreational cannabis, but the process was delayed for unknown reasons.
Cannabis Hyperemesis Syndrome Cases Have Risen With Cannabis Commercialization, Study Finds
Large increases in CHS emergency department visits were seen shortly following the wider market commercialization in Ontario, which included the opening of more retail stores and the sale of more diverse and potent products.
Denver Prioritizes Social Equity Applicants for Cannabis Delivery Licenses
The city council also voted to slash licensing fees for delivery companies in another effort to “create a more equitable cannabis marketplace.”
California Governor Signs 10 Cannabis Bills, Legalizing Interstate Cannabis Commerce
California Governor Gavin Newsom signed 10 bills on Sunday, September 18, that will enact a wide range of new cannabis policies in the state.
Cannabis Companies Use Similar Social Responsibility Practices to Big Tobacco, Study Finds
The investigators caution that public health actors should be wary of such CSR activities as they may be less effective than independent educational initiatives and serve to advance corporate interests.
